Have a personal or library account? Click to login
The influence of proteasome inhibitor on the expression of cardiomyocytes damage markers after incubation with doxorubicin Cover

The influence of proteasome inhibitor on the expression of cardiomyocytes damage markers after incubation with doxorubicin

Current Issues in Pharmacy and Medical Sciences
Volume 27 (2014): Issue 2 (June 2014)
By: Sylwia Tereszkiewicz,  Wlodzimierz Matysiak,  Slawomir Mandziuk,  Agnieszka Korga,  Malgorzata Oleksiejuk,  Marcin Hejna,  Agnieszka Korobowicz-Markiewicz,  Magdalena Iwan and  Jaroslaw Dudka  
Open Access
|Nov 2014
DOI: https://doi.org/10.2478/cipms-2014-0020 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 88 - 91
Submitted on: Jun 11, 2014
|
Accepted on: Jun 13, 2014
|
Published on: Nov 25, 2014
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
doxorubicin,
BNP,
H-FABP,
proteasom
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2014 Sylwia Tereszkiewicz, Wlodzimierz Matysiak, Slawomir Mandziuk, Agnieszka Korga, Malgorzata Oleksiejuk, Marcin Hejna, Agnieszka Korobowicz-Markiewicz, Magdalena Iwan, Jaroslaw Dudka, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 27 (2014): Issue 2 (June 2014)Next article